Immuron Ltd

IMRN chart

Immuron Ltd news

• Immuron Sales Rise 9% to AUD$2.2 Million in Q1

  grafa.com · Oct 27, 2:39 PM EDT

• Presenting on Emerging Growth Conference 97 Day 1 on October 28; Register to live stream

  Yahoo Finance · Oct 27, 7:00 AM EDT

• Immuron continued quarterly sales growth

  Yahoo Finance · Oct 27, 6:00 AM EDT

• Immuron posts $2.2M quarterly sales revenue

  grafa.com · Oct 26, 10:16 PM EDT

• Immuron Reduces ATM Facility Capacity to Approximately US$2.0 Million via Prospectus Supplement

  Kalkine · Oct 26, 10:09 PM EDT

• Travelan outsells Imodium in pharmacies as Immuron's Australian sales climb

  BiotechDispatch · Oct 26, 9:36 PM EDT

• Immuron Reports Q1 FY27 Global Sales of AUD$2.2 Million, Up 9% on Prior Year

  Kalkine · Oct 26, 7:15 PM EDT

• Immuron Lowers At-The-Market Offering Limit to $2,006,769

  Kalkine Media · Oct 23, 5:36 PM EDT

• $2.85M in prior sales are excluded as Immuron (IMRN) cuts its offering cap.

  Stock Titan · Oct 23, 5:28 PM EDT

• A 3% sales commission applies to Immuron (NASDAQ: IMRN)'s offering, now capped at about $2.01M.

  Stock Titan · Oct 23, 5:25 PM EDT

• Immuron CEO to present at Emerging Growth Confe...

  Pluang · Oct 22, 6:51 PM EDT

• Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference

  Yahoo Finance · Oct 22, 6:27 PM EDT

Immuron Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-23
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-22
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-13
• 20-FANNUAL REPORT2026-09-24
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-24
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-22
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-04
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-19
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-13

About Immuron Ltd

Ticker

IMRN (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Carlton, Victoria, Australia

Incorporated in

Australia

Fiscal year end

June 30

SEC CIK

1660046

Frequently asked questions